Kosovo’s Hospital Secures €4.26 Million in Medicine Contracts Amid Supply Crisis
Kosovo’s Clinical University Hospital Secures €4.26 Million in Medicine Contracts
The Clinical University Hospital Service of Kosovo (SHSKUK) has signed 12 contracts worth a total of €4,258,317.04 for the supply of 12 essential medicines, including treatments for anemia, cancer, and inflammatory diseases.
According to documentation published by IndeksOnline, the initial tender value was €5.5 million, divided into 14 lots based on the type of medication. SHSKUK successfully secured contracts for 12 of these lots, while contracts for two medicines—“cisplatin” and “piperacillin + tazobactam”—remain unresolved.
The awarded contracts do not exceed the pre-set values for each lot. The largest contract was won by **MEDITECH**, valued at €1,707,744 for 12,366 units of medications that stimulate red blood cell production, used in treating anemia.
Other significant contracts include:
- “Agani L.T.D SH.P.K.” – €469,440 for 2,934 units of “coagulation factor IX,” used to treat hemophilia B.
- “Santefarm” – €704,904 for 20,432 units of “etanercept,” a drug for inflammatory diseases.
- “GENE MEDICALS” and “EDNAFARMA” – €187,795 for 1,633 units of “trastuzumab,” for cancer treatment.
- “MEDI MAX” – €39,973 for 128,946 units of “midazolam,” for medical sedation.
- “DELTAPHARMA-KS” – €455,700 for 35,000 units of “nilotinib,” for leukemia treatment.
- “Santefarm” – €109,241 for 40,833 units of “sorafenib,” for liver cancer.
- “Liri-Med” – €335,172 for 9,858 units of “gemcitabine,” for cancer.
- “MEDI MAX” – €39,133 for 6,533 units of “temozolomide,” for brain tumors.
- “Liri-Med” – €121,800 for 840 units of “pemetrexed,” for lung cancer.
The supplies will be delivered through the Central Pharmacy of the Kosovo Health Ministry (QKUK) and SHSKUK, with contracts to be fulfilled within 24 months. Whether new procurement processes will begin for the remaining two medicines—“cisplatin” and “piperacillin + tazobactam”—remains unclear.
This allocation directly impacts patient care at SHSKUK, ensuring timely access to critical medications.
In Brief
SHSKUK has secured 12 contracts worth €4.26 million for medicine supplies, excluding two drug types. The contracts cover treatments for critical conditions like cancer, anemia, and hemophilia. Deliveries will be managed through the Central Pharmacy and will span 24 months.
Key Entities Mentioned
- SHSKUK - Clinical University Hospital Service of Kosovo
- MEDITECH - Winning bidder for the largest contract
- Agani L.T.D SH.P.K. - Supplier of coagulation factor IX
- Santefarm - Supplier of etanercept and sorafenib
- GENE MEDICALS SH.P.K. - Supplier of trastuzumab
- MEDI MAX SH.P.K. - Supplier of midazolam and temozolomide
- DELTAPHARMA-KS SH.P.K. - Supplier of nilotinib
- Liri-Med - Supplier of gemcitabine and pemetrexed
Word count: 598
Source: orainfo.net
Note: This content has been processed for informational purposes by Portali Kosova.Today.
Advertisement